NCT00348985 2013-05-03PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or LymphomasNational Cancer Institute (NCI)Phase 1 Completed55 enrolled
NCT00237627 2012-05-18Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast CancerUNC Lineberger Comprehensive Cancer CenterPhase 1/2 Completed107 enrolled